HOME >> BIOLOGY >> NEWS
Fertility treatments increase incidence of twins at a cost

PHILADELPHIA -- Fertility treatments can increase multiple births and, in doing so, impose long-range costs in schooling and income on the resulting children, according to researchers at the University of Pennsylvania.

On average, twins weigh 28 ounces less at birth than children born singly, and, according to Penn researchers, this translates into a 12 percent reduction in lifetime earnings for twins compared to singletons.

Penn economics professors Jere Behrman and Mark Rosenzweig are the first researchers to document the causal link between birth weights and lifetime earnings. Their report, "The Returns to Increasing Body Weight," concludes that there are "real payoffs" to interventions that help pregnant women increase their babies' weight at birth.

In 1994 and 1995, the researchers collected data on female twins from the Minnesota Twins Registry, the largest birth-certificate-based twins registry in the U.S. It contains birth records of all twins born in Minnesota between 1936 and 1955. Their empirical research focused on 404 pairs of genetically identical female twins, studying their birth weight, schooling attainment, adult height and adult earnings.

Behrman and Rosenzweig found that twins have considerably lower average birth weight (5 pounds, 10 ounces) compared to the general population (7 pounds, 6 ounces). Also, almost half of twins are low birth weight by the standard definition of low birth weight (below 5 pounds and 8 ounces.)

According to Behrman, when potential parents undergo fertility treatments that could result in multiple births, they undertake a double risk. "Not only do they take the chance of having more children than they bargained for but of having children with less satisfactory education and economic prospects than would result from a singleton birth," Behrman said.

Increasing birth weight increases adult schooling attainment, adult height and adult earnings. Augmenting a chi
'"/>

Contact: Jacquie Posey
jposey@pobox.upenn.edu
215-898-6460
University of Pennsylvania
2-Jul-2002


Page: 1 2

Related biology news :

1. Fertility study shows increased estrogen shortens window of implantation in mice
2. Fertility experts urge clinics to consider natural cycle IVF instead of routine use of ovarian stimulants
3. Discovery Of Mutation May Lead To Help For Male Fertility Problems
4. Research Suggests New Way To Gauge A Womans Fertility
5. Sperm Protein May Hold Clues For Fertility And Contraceptives
6. UB Fertility Researchers Find They Can Predict Pregnancy By Assessing Two Sperm Abnormalities
7. Poetically Timed With Spring, Budding Yeast Yield Possible Insight Into Male Fertility--And Infertility
8. Discovery By Fertility Specialist Offers Promise Of Reducing Multiple BirthsTied To Fertility Treatment
9. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
10. Genetic model for devastating form of paraplegia suggests new treatments
11. Gene profiles could improve acute leukemia diagnosis and lead to better treatments

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Fertility treatments increase incidence twins cost

(Date:10/15/2014)... the 44th Rosenstiel Award for Distinguished Work in Biomedical ... the mechanisms of genomic instability and its implications for ... second alumnus to win the Rosenstiel Award; the first, ... Alt is the Charles A. Janeway Professor of Pediatrics ... an investigator at the Howard Hughes Medical Institute at ...
(Date:10/14/2014)... shows SIRT6—a protein known to inhibit the growth ... skin cancers by turning on an enzyme that increases ... Previously considered protective, SIRT6 is part of a family ... stability and prevent some of the genetic flaws associated ... lead to cancer. This study, in the journal,s October ...
(Date:10/14/2014)... of the planet,s leading questions is how to produce ... variable climate. The Food and Agriculture Organization of the ... over the next 40 years to feed a growing ... the necessary rise in food production. Plants—grains, cereals, ... supporting livestock. Current research must tap into our ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
(Date:10/22/2014)... YORK , Oct. 22, 2014 Nuvilex, ... Federation, approximately 400 million people worldwide are living with ... million people by 2030.  The global market for diabetes ... 2012 approximately 330,000 people worldwide died from pancreatic cancer.  ... death due to cancer in the United ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: